Market Update: Regeneron, UPS, and Zebra
Regeneron (REGN) has seemingly overcome its bear phase, with shares rising 12% to over $650 on Tuesday.
The company reported a 0.8% increase in revenue to $3.75 billion, driven by strong sales of Dupixent, which reached $4.9 billion.
- Dupixent sales offset weak sales from EYLEA.
- EYLEA HD sales grew by 42% to $663 million.
Regeneron also lowered its R&D and SG&A expense forecast for the fiscal year to manage costs.
Meanwhile, UPS added 8.0% after posting non-GAAP EPS of $1.74 on revenue of $21.4 billion, despite being down nearly 25% in 2025.
The stock markets rallied after UPS announced a massive 48,000 job cut, with 34,000 cuts in the operational unit and 14,000 at the management level.
Zebra (ZBRA) continued its downtrend, which began in August and accelerated in October, with the stock losing 11%.
Author's summary: Regeneron and UPS see gains amidst job cuts.
More News
- Austin Reaves cracks viral joke after buzzer-beater lifts Lakers to win
- A sovereign alternative: Armenia’s revival, built at home and hedged on all sides (Part 2)
- Pashinyan's election campaign could lead to a split in Armenian society
- Detained bishops call for national solidarity
- Baku, Yerevan take tangible steps toward peaceful coexistence
- 10 great erotic horror films
- AFN Releases Progress Report on Canada’s Implementation of the UN Declaration on the Rights of Indigenous Peoples Act – “Accelerated Action is Needed Now” - Assembly of First Nations
- Editorial: We must stand in solidarity with the Indiana Daily Student, journalism everywhere - Daily Bruin
- For Its 80th Birthday, the U.N. Needs More Than a Reset
- The long way around: Syunik and the weight of the word